SWM
GSK icon

Stockman Wealth Management’s GSK GSK Stock Holding History

Stockman Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
270,147
+53
+0% +$2.87K 1.65% 22
2025
Q4 		$13.2M Buy
270,094
+601
+0.2% +$28K 1.54% 23
2025
Q3 		$11.6M Buy
269,493
+8,172
+3% +$319K 1.44% 26
2025
Q2 		$10M Buy
261,321
+4,120
+2% +$157K 1.36% 30
2025
Q1 		$9.96M Buy
257,201
+40,001
+18% +$1.46M 1.48% 29
2024
Q4 		$7.35M Buy
217,200
+7,683
+4% +$277K 1.15% 33
2024
Q3 		$8.57M Buy
209,517
+15,024
+8% +$615K 1.33% 29
2024
Q2 		$7.49M Buy
194,493
+3,361
+2% +$141K 1.31% 29
2024
Q1 		$8.19M Buy
191,132
+2,207
+1% +$91K 1.45% 27
2023
Q4 		$7M Buy
188,925
+4,134
+2% +$148K 1.4% 29
2023
Q3 		$6.7M Buy
184,791
+4,873
+3% +$173K 1.47% 27
2023
Q2 		$6.41M Buy
179,918
+12,876
+8% +$462K 1.38% 28
2023
Q1 		$5.94M Buy
167,042
+10,181
+6% +$356K 1.33% 29
2022
Q4 		$5.51M Buy
156,861
+4,871
+3% +$162K 1.27% 30
2022
Q3 		$4.47M Buy
151,990
+32,696
+27% +$1.24M 1.21% 33
2022
Q2 		$6.49M Buy
119,294
+2,320
+2% +$128K 1.66% 25
2022
Q1 		$6.37M Buy
116,974
+3,969
+4% +$216K 1.32% 28
2021
Q4 		$6.23M Buy
113,005
+1,333
+1% +$69.3K 1.27% 31
2021
Q3 		$5.33M Buy
111,672
+4,966
+5% +$249K 1.19% 31
2021
Q2 		$5.31M Buy
106,706
+11,127
+12% +$535K 1.27% 29
2021
Q1 		$4.26M Buy
95,579
+11,885
+14% +$539K 1.19% 34
2020
Q4 		$3.85M Buy
83,694
+6,327
+8% +$291K 1.18% 35
2020
Q3 		$3.64M Buy
77,367
+2,643
+4% +$132K 1.33% 30
2020
Q2 		$3.81M Buy
74,724
+934
+1% +$47.9K 1.43% 25
2020
Q1 		$3.5M Buy
73,790
+1,729
+2% +$92.2K 1.55% 24
2019
Q4 		$4.23M Sell
72,061
-216
-0.3% -$12K 1.5% 23
2019
Q3 		$3.86M Buy
72,277
+3,539
+5% +$182K 1.48% 24
2019
Q2 		$3.44M Buy
68,738
+1,771
+3% +$88.9K 1.4% 26
2019
Q1 		$3.5M Sell
66,967
-539
-0.8% -$26.9K 1.53% 26
2018
Q4 		$3.22M Buy
67,506
+719
+1% +$35.4K 1.54% 24
2018
Q3 		$3.35M Sell
66,787
-936
-1% -$47.6K 1.45% 28
2018
Q2 		$3.41M Sell
67,723
-1,791
-3% -$90.2K 1.56% 25
2018
Q1 		$3.4M Buy
69,514
+6,520
+10% +$304K 1.55% 24
2017
Q4 		$2.79M Buy
62,994
+4,148
+7% +$192K 1.25% 33
2017
Q3 		$2.99M Buy
58,846
+47,649
+426% +$2.42M 1.43% 27
2017
Q2 		$604K Sell
11,197
-37,942
-77% -$2.02M 0.6% 56
2017
Q1 		$2.59M Buy
49,139
+1,385
+3% +$70.3K 1.47% 28
2016
Q4 		$2.3M Buy
47,754
+7,059
+17% +$349K 1.4% 28
2016
Q3 		$2.19M Sell
40,695
-1,632
-4% -$89.5K 1.36% 31
2016
Q2 		$2.29M Sell
42,327
-3,780
-8% -$199K 1.79% 23
2016
Q1 		$2.34M Buy
46,107
+7,679
+20% +$382K 1.85% 20
2015
Q4 		$1.94M Buy
38,428
+2,547
+7% +$130K 1.57% 27
2015
Q3 		$1.73M Buy
35,881
+707
+2% +$36.8K 1.49% 28
2015
Q2 		$1.83M Buy
35,174
+6,467
+23% +$364K 1.56% 26
2015
Q1 		$1.66M Buy
28,707
+3,946
+16% +$226K 1.41% 26
2014
Q4 		$1.32M Buy
+24,761
New +$1.39M 1.13% 40

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stockman Wealth Management's GSK Position: Q1 2026 in Review

Stockman Wealth Management increased its GSK (GSK) stake by 0.02% in Q1 2026, buying an estimated $2.87K and bringing the position to 270,147 shares worth $14.9M. The position accounts for 1.65% of the portfolio, ranked #22.

Stockman Wealth Management first reported a position in GSK in Q4 2014 and has held it in 46 quarters since. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Stockman Wealth Management held 270,147 shares of GSK worth $14.9M as of Q1 2026.
  • Stockman Wealth Management bought 53 GSK shares in Q1 2026, an estimated $2.87K.
  • GSK made up 1.65% of Stockman Wealth Management's portfolio in Q1 2026, its #22 holding.
  • Stockman Wealth Management first reported a position in GSK in Q4 2014 and has held it in 46 quarters since.
  • 1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Stockman Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.